KR890014470A - 카르바펜엠 중간체의 제조방법 - Google Patents
카르바펜엠 중간체의 제조방법 Download PDFInfo
- Publication number
- KR890014470A KR890014470A KR1019890003685A KR890003685A KR890014470A KR 890014470 A KR890014470 A KR 890014470A KR 1019890003685 A KR1019890003685 A KR 1019890003685A KR 890003685 A KR890003685 A KR 890003685A KR 890014470 A KR890014470 A KR 890014470A
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- enyl
- azetidin
- carboxyprop
- producing
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims 14
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical compound O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 claims abstract 37
- 239000001257 hydrogen Substances 0.000 claims abstract 10
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 10
- 125000000547 substituted alkyl group Chemical group 0.000 claims abstract 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract 6
- 125000000217 alkyl group Chemical group 0.000 claims abstract 6
- 150000002431 hydrogen Chemical class 0.000 claims abstract 4
- 229910052751 metal Inorganic materials 0.000 claims abstract 4
- 239000002184 metal Substances 0.000 claims abstract 4
- 239000002253 acid Substances 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 6
- -1 1- (tert-butyldimethylsiloxy) ethyl Chemical group 0.000 claims 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 230000000845 anti-microbial effect Effects 0.000 claims 3
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 claims 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 2
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 claims 2
- 239000004599 antimicrobial Substances 0.000 claims 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 2
- 229910052794 bromium Inorganic materials 0.000 claims 2
- QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 claims 2
- 125000001188 haloalkyl group Chemical group 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 229910052725 zinc Inorganic materials 0.000 claims 2
- 239000011701 zinc Substances 0.000 claims 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 229910021590 Copper(II) bromide Inorganic materials 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000004423 acyloxy group Chemical group 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 125000005333 aroyloxy group Chemical group 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 125000005135 aryl sulfinyl group Chemical group 0.000 claims 1
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 claims 1
- 125000001589 carboacyl group Chemical group 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 125000001475 halogen functional group Chemical group 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000033116 oxidation-reduction process Effects 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/02—Preparation
- C07D477/04—Preparation by forming the ring or condensed ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Automobile Manufacture Line, Endless Track Vehicle, Trailer (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
내용 없음.
Description
내용없음
Claims (25)
- 4-(이탈기 치환된) 아제티딘-2-온(Ⅰ)을 식(Ⅲ)의 트랜스-2-(이탈기 치환된)메틸-3-알킬아크릴산과 환원성 금속으로 반응시킴을 특징으로 하는 4β(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-은(Ⅱ)의 제조방법.(상기식에서, R1은 수소 또는 임의로 치환된 알킬 ; R2는 임의로 치환된 알킬 ; R3은 수소 또는 카르복시보호기 ; 그리고 R4와 R5는 각각 이탈기이다.)
- 제1항에 있어서, R1이 1C 내지 10C 알킬 3C 내지 18C 히드로카르빌실릴로 임의로 보호된 1C 내지 10C 히드록시알킬, 1C 내지 8C 할로알킬, 또는 4C 내지 8C 디옥소렌일인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
- 제1항에 있어서, R1이 수소, 1C 내지 8C 알킬, 또는 1C 내지 8C 1-(임의로 보호된 히드록시 또는 할로) 알킬인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘 -2-온(Ⅱ)의 제조방법.
- 제3항에 있어서, 임의의 보호기가 1C 내지 10C카르복실계 아실, 2C 내지 10C카르본계 아실, 2C 내지 8C 에테르 형성기, 3C 내지 18C 트리히드로카르빌실릴, 7C 내지 19C 반응성 아르알킬 인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온-(Ⅲ)의 제조방법.
- 제1항에 있어서, R1이 1-히드록시에틸, 1-(3차-부틸디메틸실옥시)에틸, 또는 1-(트리에틸실릴-옥시)에틸인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
- 제1항에 있어서, R2가 1C 내지 8C알킬 또는 치환된 알킬인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
- 제1항에 있어서, R2가 1C 내지 3C알킬 또는 1C 내지 5C 할로겐알킬인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
- 제1항에 있어서, R2가 메틸 또는 에틸 인 4β-81β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
- 제1항에 있어서, R3가 수소 또는 1C 내지 8C알킬인 4β-(1β-알킬-2-카르복시프로프 -2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
- 제1항에 있어서, R3가 수소, 메틸 또는 에틸인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
- 제1항에 있어서, R4와 R5가 각각 불소, 염소, 브롬, 또는 임의로 치환된 1C 내지 8C 알칸오일옥시, 7C 내지 15C 아로일옥시, 1C 내지 8C 알킬술폰일옥시, 1C 내지 8C 치환된 알킬술폰일옥시, 6C 내지 10C 아릴술폰일옥시, 1C 내지 8C 알킬술핀일, 또는 6C 내지 10C 아릴술핀일 인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
- 제11항에 있어서, R4가 아세톡시이고 R5가 브롬인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
- 제1항에 있어서, 반응을 용매중에서 수행하는 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
- 제13항에 있어서, 용매가 테트라히드로푸란인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
- 제1항에 있어서, 환원성 금속이 -0.1 내지 -0.8 볼트의 산화-환원 전위를 갖는 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
- 제1항에 있어서, 환원성 금속이 아연인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
- 제16항에 있어서, 아연을 브롬화제 2구리로 활성 화한 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
- 제1항에 있어서, 반응을 -10 내지 50℃에서 0.5 내지 10시간동안 수행하는 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
- 제18항에 있어서, 반응을 30 내지 35℃에서 3.5시간동안 수행하는 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)의 제조방법.
- 하기식(Ⅱ)의 4β-(1β-알킬-2-카르복시-프로프-2-엔일)아제티딘-2-온(Ⅱ).(상기식에서, R1은 수소 또는 임의로 치환된 알킬 : R2는 임의로 치환된 알킬 : 그리고 R3는 수소 또는 카르복시보호기이다.)
- 제20항에 있어서, R1이 1-히드록시에틸, 1-(3차-부틸디메틸실릴옥시)에틸, 또는 1-(트리에틸실릴옥시)에틸 ; R2가 메틸 또는 에틸 ; 그리고 R3가 수소, 메틸, 또는 에틸인 4β-(1β-알킬-2-카르복시프로프-2-엔일)아제티딘-2-온(Ⅱ)화합물.
- 제1항에 있어서의 방법의 조합 및 전술한 방법과 실질적으로 동종의 반응으로 이루어진 항균물질 1-카르바펜-2-엠 화합물의 제조방법.
- 실질적으로 전술한 반응을 거쳐 제조된 항균물질 1-카르바펜-2-엠 화합물.
- 제23항에 있어서, 전술한 실시예에 기술된 것과 실질적으로 동일한 반응에 의해 제조된 항균물질 1-카르바펜-2-엠 화합물.
- 활성 성분으로서, 제23항에 청구된 1-카르바펜-2-엠을 함유하는 항균성 제제.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63-70763 | 1988-03-23 | ||
JP7076388 | 1988-03-23 | ||
JP070763/1988 | 1988-03-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR890014470A true KR890014470A (ko) | 1989-10-23 |
KR0125932B1 KR0125932B1 (ko) | 1997-12-26 |
Family
ID=13440875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890003685A KR0125932B1 (ko) | 1988-03-23 | 1989-03-23 | 카르바펜엠 중간체의 제조방법 |
Country Status (9)
Country | Link |
---|---|
US (1) | US4960879A (ko) |
EP (1) | EP0336143B1 (ko) |
KR (1) | KR0125932B1 (ko) |
AT (1) | ATE90343T1 (ko) |
AU (1) | AU613724B2 (ko) |
CA (1) | CA1340115C (ko) |
DE (1) | DE68906945T2 (ko) |
ES (1) | ES2017596T3 (ko) |
GB (1) | GB2216525B (ko) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0308867B1 (en) * | 1987-09-22 | 1995-07-26 | Shionogi Seiyaku Kabushiki Kaisha | Alkenylsilylazetidinone intermediates for carbapenems |
CA2000565C (en) * | 1988-10-19 | 1998-06-23 | Masaji Ishiguro | Process for the preparation of 4-acyloxy-2-azetidinone derivatives |
US4992545A (en) * | 1989-09-20 | 1991-02-12 | Eli Lilly And Company | Process for preparing 4-substituted azetidinones |
JPH03120280A (ja) * | 1989-10-03 | 1991-05-22 | Shionogi & Co Ltd | ハロメチルカルバペネム化合物の製法 |
FI96311C (fi) * | 1989-12-04 | 1996-06-10 | Squibb Bristol Myers Co | Menetelmä farmaseuttisesti käyttökelpoisten 6-(1-hydroksietyyli)-3-(substituoitu tio)-7-okso-1-atsabisyklo/3.2.0/hept-2-eeni-2-karboksyylihappojohdannaisten valmistamiseksi |
US5672701A (en) * | 1990-01-16 | 1997-09-30 | Bristol-Myers Squibb Company | 4-substituted alkyl carbapenem antibiotics |
US5068232A (en) * | 1990-04-10 | 1991-11-26 | American Cyanamid Company | Novel 2-substituted alkyl-3-carboxy carbapenems as antibiotics and a method of producing them |
EP0695753A1 (en) * | 1994-08-05 | 1996-02-07 | Zeneca Limited | Carbapenem derivatives containing a bicyclic substituent, process for their preparation, and their use |
US5607928A (en) * | 1994-08-05 | 1997-03-04 | Zeneca Limited | Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives |
US6216687B1 (en) | 1996-03-22 | 2001-04-17 | The Majestic Products Company | Unvented heating appliance having system for reducing undesirable combustion products |
US5973142A (en) * | 1997-01-21 | 1999-10-26 | Yasuda; Nobuyoshi | Process for synthesizing carbapenem intermediates |
AU722405B2 (en) * | 1997-01-21 | 2000-08-03 | Merck & Co., Inc. | Process for synthesizing carbapenem intermediates |
US6346617B1 (en) | 1997-08-26 | 2002-02-12 | Merck & Co., Inc. | Crystalline 2-hydroxymethyl carbapenem intermediate compounds and process for synthesis thereof |
JP2001514169A (ja) * | 1997-08-27 | 2001-09-11 | メルク エンド カムパニー インコーポレーテッド | β−メチルカルバペネム中間体の製造 |
US6143885A (en) * | 1997-08-27 | 2000-11-07 | Merck & Co., Inc. | Preparation of beta-methyl carbapenem intermediates |
US7632828B2 (en) * | 2004-06-10 | 2009-12-15 | Fob Synthesis, Inc. | Gram-positive carbapenem antibacterials and processes for their preparation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE10838T1 (de) * | 1980-02-28 | 1985-01-15 | Fujisawa Pharmaceutical Co., Ltd. | 4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung. |
JPS60158167A (ja) | 1984-01-27 | 1985-08-19 | Sumitomo Chem Co Ltd | β−ラクタム化合物の製造法 |
EP0180189B1 (en) * | 1984-10-31 | 1991-01-23 | Sumitomo Pharmaceuticals Company, Limited | Novel beta-lactams and their production |
DE3509769A1 (de) * | 1985-03-19 | 1986-09-25 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von carbapenemzwischenprodukten |
JPS6229577A (ja) | 1985-07-31 | 1987-02-07 | Sumitomo Pharmaceut Co Ltd | オキサゾリジン誘導体 |
JPS62103063A (ja) * | 1985-10-29 | 1987-05-13 | Sagami Chem Res Center | アゼチジノン誘導体の製造方法 |
-
1989
- 1989-03-03 US US07/318,717 patent/US4960879A/en not_active Expired - Lifetime
- 1989-03-09 CA CA000593434A patent/CA1340115C/en not_active Expired - Fee Related
- 1989-03-13 EP EP89104433A patent/EP0336143B1/en not_active Expired - Lifetime
- 1989-03-13 AT AT89104433T patent/ATE90343T1/de not_active IP Right Cessation
- 1989-03-13 DE DE89104433T patent/DE68906945T2/de not_active Expired - Lifetime
- 1989-03-13 ES ES89104433T patent/ES2017596T3/es not_active Expired - Lifetime
- 1989-03-22 GB GB8906597A patent/GB2216525B/en not_active Expired - Lifetime
- 1989-03-22 AU AU31599/89A patent/AU613724B2/en not_active Expired
- 1989-03-23 KR KR1019890003685A patent/KR0125932B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB2216525A (en) | 1989-10-11 |
GB2216525B (en) | 1992-01-02 |
US4960879A (en) | 1990-10-02 |
AU613724B2 (en) | 1991-08-08 |
DE68906945D1 (de) | 1993-07-15 |
ATE90343T1 (de) | 1993-06-15 |
EP0336143B1 (en) | 1993-06-09 |
CA1340115C (en) | 1998-11-03 |
KR0125932B1 (ko) | 1997-12-26 |
ES2017596A4 (es) | 1991-03-01 |
DE68906945T2 (de) | 1993-10-14 |
ES2017596T3 (es) | 1994-10-16 |
EP0336143A1 (en) | 1989-10-11 |
GB8906597D0 (en) | 1989-05-04 |
AU3159989A (en) | 1989-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR890014470A (ko) | 카르바펜엠 중간체의 제조방법 | |
KR930004306A (ko) | 피롤리딜티오카르바페넴 유도체 | |
AU600897B2 (en) | N-acyl-alpha-amino-alpha-hydroxy acetic acid ester | |
AU2740492A (en) | Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof | |
KR830007654A (ko) | 1,2-디히드로-3H-피롤로[1,2-a]피톤-1-카르복실 에스테르의 5-아로일화 방법 | |
ES531296A0 (es) | Un derivado de acido tiazolilacetico | |
JPS5549352A (en) | Cyclic iminocarboxylic acid derivative and its salt | |
HU193460B (en) | Process for production of peneme derivatives | |
JPS5559127A (en) | Novel intermediate compound for producing prostanoids and its manufacture | |
JPS55147284A (en) | Novel beta-lactam derivative and its preparation | |
KR850001065B1 (ko) | 1rs, 4sr, 5rs-4-(4, 8-디메틸-5-히드록시-7-논엔-1-일)-4-메틸-3, 8-디옥사비시클로[3.2.1] 옥탄-1-아세트산의 전합성방법 | |
KR870002147A (ko) | 7-옥소-4-티아-1-아자비사이클로(3.2.0) 헵트-2-엔 유도체의 제조 방법 | |
KR920002545A (ko) | 살균제 | |
JPS5798257A (en) | 3,4-disubstituted azetidine-2-one compound and its preparation | |
JPS5610165A (en) | Novel beta-lactam compound and its production | |
JPS57175176A (en) | Morpholine derivatives, manufacture and composition | |
US3707540A (en) | 1,3-thiazines and their preparation | |
HUT56374A (en) | Process for producing penem derivatives and pharmaceutical compositions comprising same | |
ES2033313T3 (es) | Procedimiento de sintesis de azetidinonas. | |
KR790001281B1 (ko) | 2-(펜옥시알킬설포닐이나 설피닐) 이미다졸의 제조방법 | |
HUP9903016A2 (hu) | Javított eljárás karbapenemszármazékok előállítására | |
JPS55154957A (en) | 77methyl and 77methyll88lower alkyl b*c cis or transsmorphinann66one compound | |
ES8302687A1 (es) | "procedimiento para la preparacion de derivados de 2-oxa-biciclo (3.3.0) octano". | |
GR3025451T3 (en) | Benzimidazole derivative, production thereof, antiemetic containing same as active ingredient, and intermediate for producing same. | |
MX9800042A (es) | Metodos, composiciones, y/o articulos de limpieza/saneamiento, para superficies inanimadas no alimenticias. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20110920 Year of fee payment: 15 |
|
EXPY | Expiration of term |